NCT00523107View on ClinicalTrials.gov

PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

April 30, 2008

Conditions
Fatigue
Interventions
DRUG

PG2

PG2 500 mg / 500 ml normal saline t.i.w. per week

DRUG

Placebo

500 ml normal saline t.i.w. per week

Trial Locations (1)

Unknown

Mackay Memorial Hospital, New Taipei City

Sponsors
All Listed Sponsors
lead

PhytoHealth Corporation

INDUSTRY